PharmExec Global Marketing:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive
Send Us Some Feedback
 
| Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
May 26, 2015 | ISSUE NUMBER 21 VOL 1

Top Story
Cures: The New Game-Changers
With a robust clinical portfolio, ongoing promotional presence and positive patient response, historically, brands have been able to reach standard of care status and astronomical heights over time. But new cures are changing the game for everyone, writes Mike Rutstein. ...Read more

Brand of the Year
From Care to Cure: Pharm Exec’s Brand of the Year
This year’s Pharm Exec Brand of the Year, Sovaldi and Harvoni are are a game-changer from a commercial point of view, having broken the stereotype of the sclerotic, slow-build launch cycle that appeared to be the industry’s destiny just a year ago.
...Read more

Digital Marketing According to HIPAA
How pharmaceutical companies can break through regulatory constraints to create personal, audience-driven marketing content Learn more.

Brand of the Year
Next Steps on Hepatitis C: Gilead’s Four-Point Plan
Gilead Sciences outlines its goals for the hepatitis C virus (HCV) franchise for the next 18 months.
...Read more

Patient Adherence
Balancing High-Tech with High-Touch
Loreen M. Brown discusses how technology has influenced how healthcare teams function, from leveraging and delivering care to interacting with patients throughout the patient journey
...Read more

Interview
Capturing the Cloud: A Conversation with Veeva Systems’ Matt Wallach
Pharm Exec sits down with Matt Wallach, co-founder and President of Veeva Systems, an upstart start-up whose mix of cutting-edge technology and a strong customer orientation has brought it to the top rank in providing cloud-based data management services to the life science industry.
...Read more

//Synlogic (Cambridge, MA) appointed Jose-Carlos (JC) Gutiérrez-Ramos, Ph.D., as President and Chief Executive Officer.//Sanofi’s Chief Strategy Officer, David-Alexandre Gros is the latest of the company’s C-suite executives to leave the company. The company announced news of his departure on Monday.//Takeda UK appointed Craig Adkins as its new Business Unit Director for irritable bowel disease (IBD). //Health informatics firm Aridhia (Edinburgh, UK) named Chris Roche as CEO, succeeding co-founder David Sibbald.//

August 11–12: Speed to Therapy Strategy Summit
Philadelphia, PA.


September 17–18: Immunotherapy Commercialization
Boston, MA.


February 23–24: 2016: Oncology Commercialization and Market Access
San Francisco, CA.



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Linkedin


Quick Links

House Committee Approves 21st Century Cures Legislation

Manufacturers Still Fighting Over Biosimilar Naming

Gilead Honored at Pharm Exec Brand of the Year Event

Pharm Exec eBooks Availabe as Apps